128 related articles for article (PubMed ID: 12434413)
1. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.
Garinis GA; Menounos PG; Spanakis NE; Papadopoulos K; Karavitis G; Parassi I; Christeli E; Patrinos GP; Manolis EN; Peros G
J Pathol; 2002 Dec; 198(4):442-9. PubMed ID: 12434413
[TBL] [Abstract][Full Text] [Related]
2. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
3. High frequency of concomitant nm23-H1 and E-cadherin transcriptional inactivation in primary non-inheriting colorectal carcinomas.
Garinis GA; Manolis EN; Spanakis NE; Patrinos GP; Peros G; Menounos PG
J Mol Med (Berl); 2003 Apr; 81(4):256-63. PubMed ID: 12684753
[TBL] [Abstract][Full Text] [Related]
4. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.
Shieh YS; Shiah SG; Jeng HH; Lee HS; Wu CW; Chang LC
Cancer; 2005 Sep; 104(5):1013-21. PubMed ID: 15999364
[TBL] [Abstract][Full Text] [Related]
6. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF
Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979
[TBL] [Abstract][Full Text] [Related]
8. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
[TBL] [Abstract][Full Text] [Related]
9. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
10. Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinoma.
Corn PG; Heath EI; Heitmiller R; Fogt F; Forastiere AA; Herman JG; Wu TT
Clin Cancer Res; 2001 Sep; 7(9):2765-9. PubMed ID: 11555590
[TBL] [Abstract][Full Text] [Related]
11. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance.
Chang HW; Chow V; Lam KY; Wei WI; Yuen A
Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224
[TBL] [Abstract][Full Text] [Related]
12. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.
Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I
J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268
[TBL] [Abstract][Full Text] [Related]
13. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
15. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
[TBL] [Abstract][Full Text] [Related]
16. CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.
Pilozzi E; Onelli MR; Ziparo V; Mercantini P; Ruco L
J Pathol; 2004 Nov; 204(3):289-95. PubMed ID: 15378566
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study.
Dorudi S; Sheffield JP; Poulsom R; Northover JM; Hart IR
Am J Pathol; 1993 Apr; 142(4):981-6. PubMed ID: 7682766
[TBL] [Abstract][Full Text] [Related]
18. Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients.
Koike H; Ichikawa D; Ikoma H; Otsuji E; Kitamura K; Yamagishi H
J Surg Oncol; 2004 Sep; 87(4):182-6. PubMed ID: 15334633
[TBL] [Abstract][Full Text] [Related]
19. Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression.
Maeda G; Chiba T; Okazaki M; Satoh T; Taya Y; Aoba T; Kato K; Kawashiri S; Imai K
Int J Oncol; 2005 Dec; 27(6):1535-41. PubMed ID: 16273209
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis.
Azarschab P; Porschen R; Gregor M; Blin N; Holzmann K
Genes Chromosomes Cancer; 2002 Oct; 35(2):121-6. PubMed ID: 12203775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
